167 related articles for article (PubMed ID: 36817097)
1. The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy.
Hou JY; Liu HU; Kuo CY; Liu YH; Lin JJ; Hsieh MY; Hung PC; Cheng YT; Su IC; Wang HS; Chou IJ; Lin KL
Front Neurosci; 2022; 16():1081580. PubMed ID: 36817097
[TBL] [Abstract][Full Text] [Related]
2. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
3. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
4. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
5. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
Madlener M; Strippel C; Thaler FS; Doppler K; Wandinger KP; Lewerenz J; Ringelstein M; Roessling R; Menge T; Wickel J; Kellingshaus C; Mues S; Kraft A; Linsa A; Tauber SC; Berg FT; Gerner ST; Paliantonis A; Finke A; Priller J; Schirotzek I; Süße M; Sühs KW; Urbanek C; Senel M; Sommer C; Kuempfel T; Pruess H; Fink GR; Leypoldt F; Melzer N; Malter MP;
J Neurol Sci; 2023 Feb; 445():120540. PubMed ID: 36608627
[TBL] [Abstract][Full Text] [Related]
6. Anti-glutamic acid decarboxylase antibody (GAD) syndromes may have more aggressive disease course in African Americans and early onset of presentation compare to Caucasians group.
Sriwastava S; Srinivas M; Kanna A; Yarraguntla K; Jowkar A; George E
eNeurologicalSci; 2019 Dec; 17():100208. PubMed ID: 31646204
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
8. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.
Markakis I; Alexopoulos H; Poulopoulou C; Akrivou S; Papathanasiou A; Katsiva V; Lyrakos G; Gekas G; Dalakas MC
J Neurol Sci; 2014 Aug; 343(1-2):192-4. PubMed ID: 24950904
[TBL] [Abstract][Full Text] [Related]
10. Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy.
Jaafar F; Haddad L; Koleilat N; Sharara-Chami R; Shbarou R
Epilepsy Behav Rep; 2020; 14():100396. PubMed ID: 33305253
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
Sunwoo JS; Chu K; Byun JI; Moon J; Lim JA; Kim TJ; Lee ST; Jung KH; Park KI; Jeon D; Jung KY; Kim M; Lee SK
J Neuroimmunol; 2016 Jan; 290():15-21. PubMed ID: 26711563
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].
Akaishi T; Jin K; Kato K; Itabashi H; Misu T; Tateyama M; Iwasaki M; Aoki M; Nakasato N
Rinsho Shinkeigaku; 2015; 55(11):804-9. PubMed ID: 26369378
[TBL] [Abstract][Full Text] [Related]
14. Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression.
Triplett J; Vijayan S; MacDonald A; Lawn N; McLean-Tooke A; Bynevelt M; Phatouros C; Chemmanam T
J Neuroimmunol; 2018 Oct; 323():119-124. PubMed ID: 30196824
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series.
Elkhider H; Sharma R; Kapoor N; Vattoth S; Shihabuddin B
Neurol Sci; 2022 Apr; 43(4):2669-2680. PubMed ID: 34564782
[TBL] [Abstract][Full Text] [Related]
16. Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients.
Thevarkalam M; Kannoth S; Nambiar V; Gopinath S; Mathai A; Anandakuttan A; Krishnan S; Bhaskaran R
Ann Indian Acad Neurol; 2023; 26(5):663-671. PubMed ID: 38022450
[TBL] [Abstract][Full Text] [Related]
17. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
18. Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?
Lacruz Ballester L; Fernandez-Fournier M; Puertas Muñoz I; Rodriguez Fraga O; Lastras Fernandez-Escandon C; Rodriguez de Rivera Garrido FJ; Alba Suarez EM; Tallon Barranco A
Neurol Sci; 2022 Jan; 43(1):633-641. PubMed ID: 33914193
[TBL] [Abstract][Full Text] [Related]
19. A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.
Sharma CM; Pandey RK; Kumawat BL; Khandelwal D; Gandhi P
Ann Indian Acad Neurol; 2016; 19(1):146-9. PubMed ID: 27011652
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
